CD20, CTLA4, CXCL9, IL18RAP, IL-6, SOCS2, and TNF as potential biomarkers for rheumatoid arthritis disease progression: Systematic review of RNA-seq studies
Background: rheumatoid arthritis (RA) is an autoimmune disease characterized by the occurrence of numerous and complex molecular events that hinder establishing precise biomarkers to study this disease, however, transcriptomic analysis has revealed new pathophysiological elements, suggesting that th...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-04-01
|
| Series: | Heliyon |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844025014896 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850172778260463616 |
|---|---|
| author | Jairo Javier Jattin Balcázar Daniel Felipe Galeano Sánchez Gerardo Quintana López |
| author_facet | Jairo Javier Jattin Balcázar Daniel Felipe Galeano Sánchez Gerardo Quintana López |
| author_sort | Jairo Javier Jattin Balcázar |
| collection | DOAJ |
| description | Background: rheumatoid arthritis (RA) is an autoimmune disease characterized by the occurrence of numerous and complex molecular events that hinder establishing precise biomarkers to study this disease, however, transcriptomic analysis has revealed new pathophysiological elements, suggesting that this approach may allow to supply this deficiency. Objective: to develop a systematic review of RNA sequencing (RNA-seq) studies on RA in search of potential biomarkers. Methods: a literature review for RNA-seq studies on human RA was conducted using Embase, PubMed, Web of Science, Scopus, and Cochrane databases. Rayyan was used to compile results and the top 5 up/down-regulated differentially expressed genes (DEGs) were discriminated. Results: 7496 articles were obtained across the databases, selecting 79 papers involving 2423 individuals. DEGs were determined to be at least 38125, but 255 and 124 up- and down-regulated DEGs were detected after filtering by the top 5. Most biomarkers described were related to disease progression (61 %), while the most common analysis and tissue studied were principal component analysis (52 %) and blood (39 %), respectively. The expression of CD20, CTLA4, CXCL9, IL18RAP, IL-6, SOCS2, and TNF was found to be modified after therapeutic intervention, suggesting that these are indicators of disease activity and potential therapeutic failure and thus the molecules could constitute potential biomarkers in RA. Conclusion: biomarker research via RNA-seq may allow underpinning molecular events to further understand disease progression and the impact of treatment. |
| format | Article |
| id | doaj-art-09259a832acc4ebebbc15ed66078aa9f |
| institution | OA Journals |
| issn | 2405-8440 |
| language | English |
| publishDate | 2025-04-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Heliyon |
| spelling | doaj-art-09259a832acc4ebebbc15ed66078aa9f2025-08-20T02:20:00ZengElsevierHeliyon2405-84402025-04-01119e4310810.1016/j.heliyon.2025.e43108CD20, CTLA4, CXCL9, IL18RAP, IL-6, SOCS2, and TNF as potential biomarkers for rheumatoid arthritis disease progression: Systematic review of RNA-seq studiesJairo Javier Jattin Balcázar0Daniel Felipe Galeano Sánchez1Gerardo Quintana López2Universidad Nacional de Colombia–Sede Bogotá, Facultad de Medicina, Grupo Reumavance, Carrera 45#26-85, Colombia; Universidad Nacional de Colombia–Sede Bogotá, Facultad de Ingeniería, Grupo LISI, Carrera 45#26-85, Colombia; Corresponding author. Universidad Nacional de Colombia–Sede Bogotá, Facultad de Medicina, Grupo Reumavance, Carrera 45#26-85, Colombia.Universidad Nacional de Colombia–Sede Bogotá, Facultad de Medicina, Grupo Reumavance, Carrera 45#26-85, ColombiaUniversidad Nacional de Colombia–Sede Bogotá, Facultad de Medicina, Grupo Reumavance, Carrera 45#26-85, ColombiaBackground: rheumatoid arthritis (RA) is an autoimmune disease characterized by the occurrence of numerous and complex molecular events that hinder establishing precise biomarkers to study this disease, however, transcriptomic analysis has revealed new pathophysiological elements, suggesting that this approach may allow to supply this deficiency. Objective: to develop a systematic review of RNA sequencing (RNA-seq) studies on RA in search of potential biomarkers. Methods: a literature review for RNA-seq studies on human RA was conducted using Embase, PubMed, Web of Science, Scopus, and Cochrane databases. Rayyan was used to compile results and the top 5 up/down-regulated differentially expressed genes (DEGs) were discriminated. Results: 7496 articles were obtained across the databases, selecting 79 papers involving 2423 individuals. DEGs were determined to be at least 38125, but 255 and 124 up- and down-regulated DEGs were detected after filtering by the top 5. Most biomarkers described were related to disease progression (61 %), while the most common analysis and tissue studied were principal component analysis (52 %) and blood (39 %), respectively. The expression of CD20, CTLA4, CXCL9, IL18RAP, IL-6, SOCS2, and TNF was found to be modified after therapeutic intervention, suggesting that these are indicators of disease activity and potential therapeutic failure and thus the molecules could constitute potential biomarkers in RA. Conclusion: biomarker research via RNA-seq may allow underpinning molecular events to further understand disease progression and the impact of treatment.http://www.sciencedirect.com/science/article/pii/S2405844025014896Rheumatoid arthritisRNA-SeqTranscriptomeBiomarkers |
| spellingShingle | Jairo Javier Jattin Balcázar Daniel Felipe Galeano Sánchez Gerardo Quintana López CD20, CTLA4, CXCL9, IL18RAP, IL-6, SOCS2, and TNF as potential biomarkers for rheumatoid arthritis disease progression: Systematic review of RNA-seq studies Heliyon Rheumatoid arthritis RNA-Seq Transcriptome Biomarkers |
| title | CD20, CTLA4, CXCL9, IL18RAP, IL-6, SOCS2, and TNF as potential biomarkers for rheumatoid arthritis disease progression: Systematic review of RNA-seq studies |
| title_full | CD20, CTLA4, CXCL9, IL18RAP, IL-6, SOCS2, and TNF as potential biomarkers for rheumatoid arthritis disease progression: Systematic review of RNA-seq studies |
| title_fullStr | CD20, CTLA4, CXCL9, IL18RAP, IL-6, SOCS2, and TNF as potential biomarkers for rheumatoid arthritis disease progression: Systematic review of RNA-seq studies |
| title_full_unstemmed | CD20, CTLA4, CXCL9, IL18RAP, IL-6, SOCS2, and TNF as potential biomarkers for rheumatoid arthritis disease progression: Systematic review of RNA-seq studies |
| title_short | CD20, CTLA4, CXCL9, IL18RAP, IL-6, SOCS2, and TNF as potential biomarkers for rheumatoid arthritis disease progression: Systematic review of RNA-seq studies |
| title_sort | cd20 ctla4 cxcl9 il18rap il 6 socs2 and tnf as potential biomarkers for rheumatoid arthritis disease progression systematic review of rna seq studies |
| topic | Rheumatoid arthritis RNA-Seq Transcriptome Biomarkers |
| url | http://www.sciencedirect.com/science/article/pii/S2405844025014896 |
| work_keys_str_mv | AT jairojavierjattinbalcazar cd20ctla4cxcl9il18rapil6socs2andtnfaspotentialbiomarkersforrheumatoidarthritisdiseaseprogressionsystematicreviewofrnaseqstudies AT danielfelipegaleanosanchez cd20ctla4cxcl9il18rapil6socs2andtnfaspotentialbiomarkersforrheumatoidarthritisdiseaseprogressionsystematicreviewofrnaseqstudies AT gerardoquintanalopez cd20ctla4cxcl9il18rapil6socs2andtnfaspotentialbiomarkersforrheumatoidarthritisdiseaseprogressionsystematicreviewofrnaseqstudies |